Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast

Ozsvari, B, Fiorillo, M, Bonuccelli, G et al. (6 more authors) (2017) Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. Oncotarget, 8 (40). pp. 67457-67472. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
  • Ozsvari, B
  • Fiorillo, M
  • Bonuccelli, G
  • Cappello, AR
  • Frattaruolo, L
  • Sotgia, F
  • Trowbridge, R
  • Foster, R
  • Lisanti, MP
Copyright, Publisher and Additional Information: Copyright: Ozsvari et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: antibiotic, drug design, mitochondrial ribosome, mitoribosome, mitochondria
Dates:
  • Published: 7 July 2017
  • Accepted: 17 May 2017
  • Published (online): 15 September 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Maths and Physical Sciences (Leeds) > School of Chemistry (Leeds) > Organic Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 10 Oct 2017 09:48
Last Modified: 08 Dec 2017 17:43
Status: Published
Publisher: Impact Journals
Identification Number: https://doi.org/10.18632/oncotarget.19084

Share / Export

Statistics